识别与多发性骨髓瘤发展相关的潜在免疫相关机制
Yaomei Wang1, Wenli Zhang1,2, Tiandong Li3
1Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan 450008, China.
Chinese medical journal
|June 6, 2024
概括
多发性髓瘤 (MM) 患者表现出明显的骨髓免疫细胞,包括免疫抑制单细胞/巨细胞. 准这些巨细胞可以为MM提供一种新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 多发性骨髓瘤 (MM) 治疗的进步已经改善了结果,但复发仍然很常见,需要对免疫微环境有更深入的了解.
- 单细胞/巨细胞在未经治疗的MM中的作用尚未完全理解,这阻碍了治疗策略的开发.
研究的目的:
- 研究免疫微环境,专注于单细胞/巨细胞,在以前未经治疗的多发性骨髓瘤患者中.
- 描述健康捐赠者和MM患者骨髓免疫细胞中的分子和细胞差异.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 用于分析来自MM患者和健康捐助者的骨髓免疫细胞.
- 转录组数据和流细胞测量被用来检查未经治疗的MM.的单细胞/巨细胞.
主要成果:
- scRNA-seq揭示了骨髓免疫细胞的显著差异,其中富含IFN诱导的NK/T细胞,TEMRA细胞,ISG+Th细胞,耗尽的T细胞,MRC1+DCs,IFN响应的DCs,MHCII+DCs,以及MM患者的免疫抑制单细胞/巨细胞.
- 单细胞/巨细胞转录组显示了"不要吃我"和IFN诱导基因的增加,以及MM患者中较高的比例和CD16表达.
- 细胞-细胞通信分析确定了涉及单细胞/巨细胞的MIF和IL-16信号通路,作为未经治疗的MM的关键参与者.
结论:
- 这项研究提供了MM患者骨髓免疫细胞的详细分子概况,特别是单细胞/巨细胞.
- 向巨细胞为多发性骨髓瘤患者提供了一个潜在的新型治疗策略.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.1K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:27Cytotoxic T Cells-mediated Immune Response
891
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
891